Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

Our Priority: Ensure Patient Access to PSA Testing & Reform the U.S. Preventative Services Task Force (USPSTF) Recommendation Process

Why the Issue Matters

Prostate cancer is the second-leading cause of cancer deaths for men in the U.S. About 1 in 9 men will be diagnosed with prostate cancer in their lifetime. This year, nearly 191,000 men will be diagnosed with prostate cancer. Despite this, patient access to screening for prostate cancer has been threatened by state and federal agencies as well as public and private payors.

The AUA is committed to preserving patients' access to appropriate prostate cancer testing and is working at both the federal and state levels to educate lawmakers on this important issue.

The U.S. Preventive Services Task Force (USPSTF) is a government task force comprised of members from the fields of primary care and preventive medicine, which currently makes evidence-based recommendations about clinical preventive services without consulting patients or specialists in the management of related conditions. Through the USPSTF Transparency and Accountability Act, the AUA is actively working with lawmakers to reform this government body, creating transparency and accountability within the task force while also incorporating input and feedback from patients and specialists involved in treating the conditions for which recommendations are being developed. Since 2012, the AUA has advocated in support of the USPSTF Transparency and Accountability Act.

USPSTF recommendations on clinical preventive health services have created confusion among patients and the primary care community for years. For example, in May 2012 the USPSTF recommended against the prostate-specific-antigen (PSA) based screening test for prostate cancer in all men, regardless of risk. This decision counters the informed opinion of expert physicians, as well as decades of data and research showing early detection of prostate cancer, when in its most manageable state saves lives The insulated USPSTF process disallows meaningful contributions from medical specialists and the public who, in this case, would have provided evidence on the benefit of PSA-based screening in vulnerable populations including African Americans and men with a family history of the disease.

Fast Facts


What the AUA is Doing

H.R. 1176, PSA Screening for HIM Act – introduced by Reps. Bobby Rush (D-IL-01) and Larry Bucshon, MD (R-IN-08) – would waive cost-sharing, including deductibles, copayments, and coinsurances, for prostate cancer screenings for men who have a family history of prostate cancer or who are African-American.